Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Delayed Quote USD

Carisma Therapeutics, Inc. (CARM)

Compare
0.1920
-0.0089
(-4.43%)
At close: April 17 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,632
19,632
14,919
9,834
--
Operating Expense
81,811
81,811
103,650
65,996
40,794
Operating Income
-62,179
-62,179
-88,731
-56,162
-40,794
Net Non Operating Interest Income Expense
1,702
1,702
1,936
-3,145
10
Other Income Expense
--
--
-84
-1,919
--
Pretax Income
-60,477
-60,477
-86,879
-61,226
-40,784
Net Income Common Stockholders
-60,477
-60,477
-86,879
-61,226
-40,784
Diluted NI Available to Com Stockholders
-60,477
-60,477
-86,879
-61,226
-40,784
Basic EPS
-1.46
-1.46
-2.59
-1.52
-1.01
Diluted EPS
-1.46
-1.46
-2.59
-1.52
-1.01
Basic Average Shares
41,456.2100
41,456.2100
33,524.1970
40,254.6660
40,254.6660
Diluted Average Shares
41,456.2100
41,456.2100
33,524.1970
40,254.6660
40,254.6660
Total Operating Income as Reported
-62,179
-62,179
-88,731
-56,162
-40,794
Total Expenses
81,811
81,811
103,650
65,996
40,794
Net Income from Continuing & Discontinued Operation
-60,477
-60,477
-86,879
-61,226
-40,784
Normalized Income
-60,477
-60,477
-86,795
-59,307
-40,784
Interest Income
1,702
1,702
1,936
--
10
Interest Expense
--
--
--
3,145
--
Net Interest Income
1,702
1,702
1,936
-3,145
10
EBIT
-62,179
-62,179
-88,731
-58,081
-40,794
EBITDA
-58,825
-58,825
-85,894
-56,188
-40,112
Reconciled Depreciation
3,354
3,354
2,837
1,893
682
Net Income from Continuing Operation Net Minority Interest
-60,477
-60,477
-86,879
-61,226
-40,784
Total Unusual Items Excluding Goodwill
--
--
-84
-1,919
--
Total Unusual Items
--
--
-84
-1,919
--
Normalized EBITDA
-58,825
-58,825
-85,810
-54,269
-40,112
12/31/2021 - 2/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TSBX Turnstone Biologics Corp.
0.3300
-3.79%
 
SLGL Sol-Gel Technologies Ltd.
0.5500
+7.84%
 
QTTB Q32 Bio Inc.
2.1200
+14.59%
 
ATNF 180 Life Sciences Corp.
0.8985
+10.79%
 
PALI Palisade Bio, Inc.
0.7199
+2.80%
 
CASI CASI Pharmaceuticals, Inc.
1.9389
+0.46%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
VRAX Virax Biolabs Group Limited
0.9935
-3.54%
 
LGVN Longeveron Inc.
1.4600
+3.55%
 
ORMP Oramed Pharmaceuticals Inc.
2.1500
-2.27%